BMC Nephrology Impact Factor
BMC Nephrology has a 2025 Journal Impact Factor of 2.9. Verify the five-year JIF, ISSN, source boundary, and what this metric means.
Journal evaluation
Want the full journal picture?
See scope, selectivity, submission context, and what editors actually want before you decide whether the journal is realistic.
Quick answer: BMC Nephrology has a 2025 Journal Impact Factor (JIF) of 2.9. Its official Springer Nature profile also lists a five-year JIF of 3.0, a median 11 days to first decision, 4.9M downloads in 2025, open-access publishing, and eISSN 1471-2369. Cite the number as a 2025 JIF released in 2026, then keep it separate from a decision about whether a kidney-research manuscript fits the journal.
Last reviewed: July 14, 2026. Evidence basis: BMC Nephrology's official Springer Nature profile and Clarivate JCR release context.
What is the BMC Nephrology impact factor at a glance?
Metric or identifier | Current value | Evidence boundary |
|---|---|---|
Journal Impact Factor | 2.9 (2025 JIF) | Official Springer Nature display |
Five-year Journal Impact Factor | 3.0 (2025) | Official Springer Nature display |
Submission to first decision | Median 11 days | Publisher aggregate; not a review or acceptance promise |
Publishing model | Open access | Official Springer Nature display |
Downloads | 4.9M (2025) | Journal-level reach context |
CiteScore | 3.6 | Secondary exact-title context; not a JIF substitute |
Exact title | BMC Nephrology | Official Springer Nature display |
eISSN | 1471-2369 | Official Springer Nature display |
Publisher | Springer Nature | Official Springer Nature display |
The 2.9 JIF is the current two-year citation-window measure displayed by
the publisher. The 3.0 five-year JIF uses a longer window. Neither number
predicts the citations, review outcome, or clinical impact of an individual
article.
For formal promotion, funding, or institutional reporting, follow the
bibliometrics access route required by that institution. This page records a
current publisher display and exact journal identifiers; it is not a licensed
JCR export.
Is this the exact BMC Nephrology journal?
The BMC name alone is insufficient. BMC Nephrology is the open-access
Springer Nature journal that covers prevention, diagnosis, and management of
kidney and associated disorders, including related molecular genetics,
pathophysiology, and epidemiology. Its eISSN is 1471-2369.
Do not reuse this number for BMC Medicine, BMC Urology, BMC Cardiovascular
Disorders, or another BMC title. Their scopes, identifiers, article mixes, and
metrics differ. The useful artifact for this query is an exact-record check:
Verify before citing | Match | Why it matters |
|---|---|---|
Journal title | BMC Nephrology | BMC is a publisher family, not a single journal |
Identifier | eISSN 1471-2369 | Stops an adjacent BMC record from being substituted |
Citation year | 2025 | Identifies the citations used by the JIF |
Release context | 2026 | Avoids calling it a 2026 citation-year metric |
Source | Current Springer Nature profile | Keeps the lookup tied to a primary display |
BMC Nephrology impact factor trend: source boundary
The official Springer Nature profile is the source for the current **2025 JIF
of 2.9** and five-year JIF of 3.0. It does not publish a year-by-year table on
the profile checked for this page. An exact-title secondary record lists a
2024 JIF of 2.4 and the same 2025 JIF of 2.9. The secondary record's
JIF increased from 2.4 to 2.9, a difference of 0.5, but it is included only as a labeled cross-check,
not as a substitute for the official current display or a forecast.
JIF data year | JIF | Source boundary |
|---|---|---|
2024 | 2.4 | Secondary exact-title Bioxbio record |
2025 | 2.9 | Official Springer Nature display; also listed by the secondary record |
Do not extend this two-point comparison into a multi-year chart or a claim
that the metric will continue rising. A defensible historical series needs a
source that identifies every data year and its provenance.
How should the 2.9 JIF and 3.0 five-year JIF be read?
They are different journal-level citation windows, not competing quality
scores. The five-year JIF can provide longer-window context, but it does not
make a manuscript more likely to fit, pass editorial assessment, or help a
reader decide whether its clinical or mechanistic claim is adequately
supported.
Decision | Better evidence than a JIF alone | Reason |
|---|---|---|
Is this the exact journal? | Title and eISSN | Prevents a record collision |
Is the metric current? | 2025 JIF plus 2026 release context | Keeps data and release years distinct |
Does the paper fit? | Current scope, research question, evidence, and intended readers | Citation averages cannot determine editorial fit |
Is a deadline workable? | Current publisher workflow and the actual deadline | A median first decision is not the full publication process |
Is an article clinically useful? | Design, population, endpoints, analysis, and limitations | Journal metrics cannot validate a study claim |
Named failure pattern: BMC family substitution
The main failure pattern on this query is BMC family substitution: a
reader finds a plausible number for a BMC title and assumes it belongs to the
target journal. The preventative check is small but auditable: title, eISSN,
data year, release year, and source must all agree before the metric is reused.
A second error is citation-year drift. A JIF released in 2026 can be
mistakenly described as a 2026 JIF even though the publisher labels it as
- State both facts where the distinction matters: "2025 JIF of 2.9,
released in 2026."
The third error is metric-to-manuscript inference. A JIF is an average
journal citation measure. It does not establish whether a renal cohort is
appropriate, whether the outcome and follow-up support the conclusion,
whether causal language is justified, or whether the methods are reproducible.
What does the publisher source establish, and what does it not establish?
The official profile supports a current snapshot: BMC Nephrology is an
open-access Springer Nature journal with a 2025 JIF of 2.9, a five-year JIF of
3.0, a publisher-displayed median 11-day first decision, and 4.9M downloads in
- The secondary exact-title record lists a CiteScore of 3.6; CiteScore is
an Elsevier metric and must not be substituted for the JIF. The primary source does not establish an acceptance rate, APC, annual metric trend,
quartile, or likely outcome for a particular submission. Those facts require
their own current sources.
This boundary is important in clinical work. A journal-level metric cannot
replace checking a study's population, kidney-disease definition, comparator,
outcomes, missing-data handling, statistical analysis, and limitations. It
also cannot tell an author whether the paper belongs in a broad nephrology
audience rather than a more specialized clinical, epidemiology, or basic
research venue.
How should the 11-day first-decision median be used?
The publisher's 11-day median is an aggregate planning signal for the
initial decision. It is not a promise that peer review will finish in 11 days,
that a paper will be accepted, or that publication will meet a thesis, grant,
or clinical deadline. Editorial assessment, reviewer availability, revision,
and production are separate stages.
Use the current author guidance for the next submission action. If the open
question is whether the manuscript's kidney-research evidence is ready for the
intended audience, a manuscript readiness check evaluates that manuscript-level question; the JIF cannot.
What should authors verify before citing the BMC Nephrology impact factor?
- Match BMC Nephrology and eISSN 1471-2369, not a BMC publisher label.
- Describe the number as a 2025 JIF of 2.9 released in 2026.
- Keep the five-year JIF of 3.0 distinct from the two-year JIF of 2.9.
- Use the primary Springer Nature profile for this current lookup and the
institution's required JCR route for formal bibliometrics.
- Verify scope, article type, fees, and policies directly in current author
guidance, because they are distinct from a metric lookup.
For broader selection, use the best nephrology journals guide and the journal selection guide. They answer different reader jobs and should not compete for an exact BMC Nephrology metric query.
Submit If
- You need a current, exact-title BMC Nephrology JIF with a primary-source boundary.
- You have already assessed the manuscript against the journal's kidney-research scope.
- You need a present metric snapshot, not a speculative historical trend or acceptance prediction.
Think Twice If
- The target is another BMC title and the title or ISSN has not been checked.
- A journal-level citation number is being used as evidence that an individual paper will be accepted, reviewed in a fixed time, or cited at a particular rate.
- A formal quartile, fee, acceptance rate, or long-run trend is required but is not on the primary source used here.
Bottom line
BMC Nephrology's official current profile gives a 2025 Journal Impact Factor of 2.9 and a five-year JIF of 3.0. The supporting exact-title record lists 2.4 for 2024, but the verified current primary snapshot remains the correct source for the 2025 value. Confirm the exact title and eISSN 1471-2369, label the 2025 citation year and 2026 release context correctly, and separate a journal metric from a manuscript-fit decision.
Frequently asked questions
BMC Nephrology has a 2025 Journal Impact Factor of 2.9 on its official Springer Nature journal profile. The data year is 2025; the JIF release is in 2026.
Springer Nature lists a five-year Journal Impact Factor of 3.0 for BMC Nephrology, which uses a longer citation window than the current two-year JIF.
Yes. The official Springer Nature profile identifies BMC Nephrology as an open-access journal.
BMC Nephrology uses electronic ISSN 1471-2369. Confirm the exact title and ISSN before using any directory metric.
No. The JIF is a journal-level citation metric. Manuscript fit depends on the kidney or related clinical research question, evidence, audience, and the journal's current scope.
Sources
Before you upload
Want the full journal picture?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Anthropic Privacy Partner. Zero-retention manuscript processing.